神经保护
少突胶质细胞
神经科学
髓鞘
医学
多发性硬化
冲程(发动机)
神经营养因子
白质
缺血
病理生理学
缺血性中风
神经营养素
生物信息学
小胶质细胞
中风恢复
血运重建
细胞疗法
缺血性损伤
生物
治疗方法
细胞
髓鞘碱性蛋白
中枢神经系统
神经退行性变
信号转导
再髓鞘化
细胞生物学
作者
Xingyang Wang,Zixuan Ding,Yanhong Song,Ziyi Wu,Weiwei Yu,Ping Zhao,Hang Xue
标识
DOI:10.1177/0271678x261508669
摘要
Ischemic stroke remains a leading cause of mortality and long-term disability worldwide. Although revascularization therapies have improved outcomes in certain patients, effective interventions for neurological deficits are still lacking. White matter injury plays a central role in driving persistent functional impairments. As the cellular foundation for myelin regeneration, oligodendrocyte precursor cells (OPCs) have emerged as a promising therapeutic target. This review systematically examines the pathophysiological alterations of OPCs following ischemic stroke, including their proliferation, migration, differentiation, and maturation into myelinating oligodendrocytes, and explores their dynamic interactions with the surrounding microenvironment, including microglia, astrocytes, neurons, and endothelial cells. Accumulating evidence indicates that OPCs not only facilitate myelin repair through differentiation into oligodendrocytes but also contribute to neuroprotection and vascular remodeling by secreting neurotrophic and pro-angiogenic factors. Therapeutic strategies aimed at preserving OPCs and enhancing their differentiation, including pharmacological therapy, cell transplantation, gene therapy, bioengineering and biomaterials technology, as well as rehabilitation and physical therapy, hold considerable promise for improving neurological recovery. By positioning OPC dysfunction as a driver of persistent disability, this review outlines a translational pathway toward therapies that restore white matter integrity and functional recovery after ischemic stroke.
科研通智能强力驱动
Strongly Powered by AbleSci AI